PAR 12 Nov 2025, 8:37 AM

PAR Engages NBCD to Expand P3 Global Footprint

Paradigm Biopharmaceuticals Ltd

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in